|1.||Miyazaki, Kaoru: 4 articles (06/2014 - 10/2003)|
|2.||Higashi, Shouichi: 3 articles (06/2014 - 10/2003)|
|3.||Miyagi, Yohei: 2 articles (06/2014 - 04/2012)|
|4.||Watanabe, Naoko: 2 articles (06/2014 - 04/2012)|
|5.||Komiya, Eriko: 2 articles (06/2014 - 04/2012)|
|6.||Miyazaki, K: 2 articles (07/2001 - 05/2000)|
|7.||Ise, Marii: 1 article (06/2014)|
|8.||Sato, Hiroki: 1 article (06/2014)|
|9.||Furuya, Momoko: 1 article (04/2012)|
|10.||Yancopoulos, George D: 1 article (07/2009)|
|1.||Colorectal Neoplasms (Colorectal Cancer)
07/20/2001 - "In the present immunohistochemical study, we examined expression of angiomodulin in human colorectal cancer and its relationship with prognosis. "
07/20/2001 - "Angiomodulin showed correlations with poor prognosis, indicating that it may be a useful prognostic marker in patients with colorectal cancer."
07/20/2001 - "Expression of angiomodulin (tumor-derived adhesion factor/mac25) in invading tumor cells correlates with poor prognosis in human colorectal cancer."
04/01/2012 - "To elucidate roles of angiomodulin (AGM) in tumor progression, we here examined distribution of AGM in three types of human cancer tissues by immunohistochemistry. "
07/20/2001 - "The Kaplan-Meier life table revealed that patients with angiomodulin-positive tumor cells had a shorter survival time than those with negative cells (p < 0.01). "
07/20/2001 - "Early recurrence within 12 months after surgery was higher in patients with angiomodulin-expressing cancer than in those without (p < 0.05). "
07/20/2001 - "In 37 cases (41.6%), angiomodulin was expressed in invading cancer cells. "
08/06/1996 - "Specific accumulation of tumor-derived adhesion factor in tumor blood vessels and in capillary tube-like structures of cultured vascular endothelial cells."
08/06/1996 - "Tumor-derived adhesion factor (TAF) was previously identified as a cell adhesion molecule secreted by human bladder carcinoma cell line EJ-1. "
11/01/1999 - "Angiomodulin (AGM/TAF/mac25) is a 30-kDa glycoprotein that was identified as an integrin-independent cell adhesion protein secreted by human bladder carcinoma cells. "
12/01/1996 - "Tumor-derived adhesion factor (TAF) has been purified as a major secretory protein with cell-adhesion activity from culture medium conditioned by human bladder carcinoma cells (K. "
10/17/2003 - "Insulin-like growth factor (IGF) binding protein-related protein-1 (IGFBP-rP1) was previously identified as tumor-derived adhesion factor (TAF) secreted from human bladder carcinoma cells. "
05/19/2000 - "Structural requirements of heparan sulfate for the binding to the tumor-derived adhesion factor/angiomodulin that induces cord-like structures to ECV-304 human carcinoma cells."
|4.||Prostatic Neoplasms (Prostate Cancer)
|5.||Pancreatic Neoplasms (Pancreatic Cancer)
|1.||tumor-derived adhesion factor
|3.||Carrier Proteins (Binding Protein)
|4.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|7.||Insulin-Like Growth Factor Binding Proteins
|8.||Conditioned Culture Media
|9.||Proteins (Proteins, Gene)